9-氮杂双环[3.3.1]壬烷盐酸盐 | 6760-43-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 9-氮杂双环[3.3.1]壬烷盐酸盐
• 英文名称: 9-azabicyclo[3.3.1]nonane hydrochloride
• 英文别名: 9-Azoniabicyclo[3.3.1]nonane;chloride；9-azoniabicyclo[3.3.1]nonane;chloride
• CAS: 6760-43-6
• 化学式: C₈H₁₅N*ClH
• 分子量: 161.675
• InChiKey: XYOCMQKKTWWRKH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12
• 氢给体数：
  2
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090
• 储存条件：
  室温

反应信息

• 作为反应物：
  描述：

  9-氮杂双环[3.3.1]壬烷盐酸盐 在 吡啶 作用下， 以 二氯甲烷 为溶剂， 反应 21.0h， 生成 O-methyl-9-acetyl-9-azabicyclo<3.3.1>nonanium fluorosulfonate
  参考文献：
  名称：

  Bredt's rule kinetically stabilized nitrogen-centered radical cations and radicals in the 9-azabicyclo[3.3.1]nonyl system

  摘要：

  DOI：

  10.1021/ja00522a044
• 作为产物：
  描述：

  在 甲醇 作用下， 生成 9-氮杂双环[3.3.1]壬烷盐酸盐
  参考文献：
  名称：

  Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains

  摘要：

  A series of benzoxathiin SERAMs with bicyclic amine side chains was prepared. Minor modifications in the side chain resulted in significant effects or, biological activity, especially in uterine tissue. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.05.074

文献信息

• [EN] COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS<br/>[FR] COMPOSÉS UTILES POUR LE TRAITEMENT DE TROUBLES DU TRACTUS DIGESTIF
  申请人：ARDELYX INC

  公开号：WO2018129552A1

  公开（公告）日：2018-07-12

  The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist- induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders.

  本公开涉及化合物和治疗与液体潴留或盐过多有关的疾病的方法，例如心力衰竭（特别是充血性心力衰竭）、慢性肾病、晚期肾病、肝病和过氧化物酶体增殖物激活受体（PPAR）γ激动剂诱导的液体潴留。本公开还涉及化合物和治疗高血压的方法。本公开还涉及化合物和治疗胃肠道疾病的方法，包括治疗或减轻与胃肠道疾病相关的疼痛。
• [EN] S1P AND/OR ATX MODULATING AGENTS<br/>[FR] MODULATEURS DE S1P ET/OU DE L'ATX
  申请人：BIOGEN IDEC INC

  公开号：WO2014152725A1

  公开（公告）日：2014-09-25

  Compounds of formula (I), and pharmaceutically acceptable salts thereof, can modulate the activity of one or more SIP receptors and/or the activity of autotaxin (ATX). Formula (1)

  公式(I)的化合物及其药用盐可以调节一个或多个SIP受体的活性和/或自体毒素酶（ATX）的活性。公式（1）
• Second-Generation Palladium Catalyst System for Transannular C–H Functionalization of Azabicycloalkanes
  作者：Pablo J. Cabrera、Melissa Lee、Melanie S. Sanford

  DOI：10.1021/jacs.8b02142

  日期：2018.4.25

  ligands are shown to be highly effective for increasing the reaction rate, yield, and scope of Pd-catalyzed transannular C-H arylation reactions of azabicyclo[3.1.0]hexane, azabicyclo[3.1.1]heptane, azabicyclo[3.2.1]octane, and piperidine derivatives. Mechanistic studies reveal that the pyridine/quinoline-carboxylates play a role in impeding both reversible and irreversible catalyst decomposition

  本文介绍了用于脂环胺跨环 CH 功能化的第二代催化剂系统的开发。吡啶-和喹啉-羧酸盐配体被证明对于提高 Pd 催化的氮杂双环[3.1.0]己烷、氮杂双环[3.1.1]庚烷、氮杂双环[的跨环 CH 芳基化反应的反应速率、产率和范围非常有效。 3.2.1]辛烷和哌啶衍生物。机理研究表明，吡啶/喹啉-羧酸盐在阻碍可逆和不可逆催化剂分解途径方面发挥作用。这些配体首次报道了普遍存在的托烷、7-氮降冰片烷和同托烷核心的跨环 CH 芳基化的实例。最后，
• COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS
  申请人：BIOGEN IDEC MA INC.

  公开号：US20150203515A1

  公开（公告）日：2015-07-23

  Compounds of formula (I) can modulate the activity of one or more SIP receptors and/or the activity of autotaxin (ATX).

  式(I)的化合物可以调节一个或多个SIP受体的活性和/或自体向素（ATX）的活性。
• ATX MODULATING AGENTS
  申请人：BIOGEN IDEC MA INC.

  公开号：US20150210647A1

  公开（公告）日：2015-07-30

  Disclosed are bicyclic aryl compounds of formula (I), that can modulate the activity of the autotaxin (ATX) enzyme. This invention further relates to compounds that are ATX inhibitors, and methods of making and using such compounds in the treatment of demyelination due to injury or disease, as well as for treating proliferative disorders such as cancer.

  本发明公开了式（I）的双环芳基化合物，可以调节自体移行素（ATX）酶的活性。本发明还涉及ATX抑制剂化合物以及制备和使用这种化合物治疗因损伤或疾病引起的脱髓鞘和治疗增生性疾病如癌症的方法。

表征谱图